Percutaneous mitral commissurotomy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 35: Line 35:


===Rheumatic Heart Disease (DO NOT EDIT) <ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>===
===Rheumatic Heart Disease (DO NOT EDIT) <ref name="pmid18820172">{{cite journal |author=Bonow RO, Carabello BA, Chatterjee K, ''et al.'' |title=2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=118 |issue=15 |pages=e523–661 |year=2008 |month=October |pmid=18820172 |doi=10.1161/CIRCULATIONAHA.108.190748 |url=}}</ref>===


{|class="wikitable"
{|class="wikitable"
Line 41: Line 40:
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
| colspan="1" style="text-align:center; background:LightGreen"|[[ACC AHA guidelines classification scheme#Classification of Recommendations|Class I]]
|-
|-
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Percutaneous or surgical MV commissurotomy is indicated when anatomically possible for treatment of severe [[Mitral stenosis|MS]], when clinically                                      indicated. ([[ACC AHA guidelines classification scheme#Level of Evidence|Level C]])<nowiki>"</nowiki>
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.''' Percutaneous or surgical MV commissurotomy is indicated when anatomically possible for treatment of severe [[Mitral stenosis|MS]], when clinically                                      indicated. ''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence: C]])''<nowiki>"</nowiki>
|}
|}



Revision as of 18:25, 7 November 2012

WikiDoc Resources for Percutaneous mitral commissurotomy

Articles

Most recent articles on Percutaneous mitral commissurotomy

Most cited articles on Percutaneous mitral commissurotomy

Review articles on Percutaneous mitral commissurotomy

Articles on Percutaneous mitral commissurotomy in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Percutaneous mitral commissurotomy

Images of Percutaneous mitral commissurotomy

Photos of Percutaneous mitral commissurotomy

Podcasts & MP3s on Percutaneous mitral commissurotomy

Videos on Percutaneous mitral commissurotomy

Evidence Based Medicine

Cochrane Collaboration on Percutaneous mitral commissurotomy

Bandolier on Percutaneous mitral commissurotomy

TRIP on Percutaneous mitral commissurotomy

Clinical Trials

Ongoing Trials on Percutaneous mitral commissurotomy at Clinical Trials.gov

Trial results on Percutaneous mitral commissurotomy

Clinical Trials on Percutaneous mitral commissurotomy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Percutaneous mitral commissurotomy

NICE Guidance on Percutaneous mitral commissurotomy

NHS PRODIGY Guidance

FDA on Percutaneous mitral commissurotomy

CDC on Percutaneous mitral commissurotomy

Books

Books on Percutaneous mitral commissurotomy

News

Percutaneous mitral commissurotomy in the news

Be alerted to news on Percutaneous mitral commissurotomy

News trends on Percutaneous mitral commissurotomy

Commentary

Blogs on Percutaneous mitral commissurotomy

Definitions

Definitions of Percutaneous mitral commissurotomy

Patient Resources / Community

Patient resources on Percutaneous mitral commissurotomy

Discussion groups on Percutaneous mitral commissurotomy

Patient Handouts on Percutaneous mitral commissurotomy

Directions to Hospitals Treating Percutaneous mitral commissurotomy

Risk calculators and risk factors for Percutaneous mitral commissurotomy

Healthcare Provider Resources

Symptoms of Percutaneous mitral commissurotomy

Causes & Risk Factors for Percutaneous mitral commissurotomy

Diagnostic studies for Percutaneous mitral commissurotomy

Treatment of Percutaneous mitral commissurotomy

Continuing Medical Education (CME)

CME Programs on Percutaneous mitral commissurotomy

International

Percutaneous mitral commissurotomy en Espanol

Percutaneous mitral commissurotomy en Francais

Business

Percutaneous mitral commissurotomy in the Marketplace

Patents on Percutaneous mitral commissurotomy

Experimental / Informatics

List of terms related to Percutaneous mitral commissurotomy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Joanna J. Wykrzykowska, M.D.

Percutaneous Mitral Commissurotomy

Patient selection

  1. Mitral stenosis due to rheumatic disease is becoming less common in the US but is very prevalent worldwide
  2. Symptoms of shortness of breath and valve area or less than 1.5 cm2 are indications for commissurotomy
  3. Unlike with the surgical approach, elevated pulmonary pressures or depressued LV function are not contraindications
  4. Wilkins score that describes valve anatomy is the best predictor of procedural success: it assigns points for leaflet mobility, valvular and subvulvular thickening and calcification degree (score of < 8 makes the patient a favorable candidate); Thus good quality echocardiogram is essential before qualifying the patient for the procedure
  5. Contraindications include presence of left atrial appendage clot, moderate to severe mitral regurgitation or other indications for open heart surgery

Technique

  1. Transvenous transeptal technique is most commonly used with the Inoue balloon system
  2. Fossa ovalis lies usually at 1-7 o’clock but this orientation can be distorted in the presence of mitral stenosis where the interatrial septum becomes more flat, horizontal and lower
  3. For the femoral vein approach a 70 cm Brockenbrough needle should be used or an 8 Fr Mullins sheath and advanced under fluoroscopic guidance with pressure monitoring
  4. The latter is necessary to monitor for puncture into adjacent structures such as aorta
  5. Further catheter manipulation may be necessary to direct the catheter into the left ventricle through the mitral valve rather than towards one of the pulmonary veins
  6. Mullins sheath is exchanged for a solid-core coiled 0.025 inch guidewire over which a 14 Fr dilator is placed
  7. This is exchanged for the Inoue balloon (24-30 mm) which inflates in three stages allowing for balloon self-positioning with the last inflation resulting in commisural splitting

Outcomes

  1. Results of the commisurotomy should be assessed with hemodynamics and echocardiography
  2. If second inflation is needed mitral regurgitation should be assessed
  3. In general increasing valve area to greater than 1 cm2/m2 is an acceptable result
  4. Usually the valve area doubles and the pulmonary pressures degrease immediately
  5. 5 year survival is in the 90% range

Complications

  1. Usually less than 5% with low mortality
  2. Failure to puncture the interatrial septum is the most common reason for aborted procedure
  3. Most common complication is development of severe mitral regurgitation

2008 and Incorporated 2006 ACC/AHA Guidelines for the Management of Patients with Valvular Heart Disease (DO NOT EDIT) [1]

Rheumatic Heart Disease (DO NOT EDIT) [1]

Class I
"1. Percutaneous or surgical MV commissurotomy is indicated when anatomically possible for treatment of severe MS, when clinically indicated. (Level of Evidence: C)"

Sources

  • 2008 and incorporated 2006 ACC/AHA Guidelines incorporated into the 2006 guidelines for the management of patients with valvular heart disease [1]

References

  1. 1.0 1.1 1.2 Bonow RO, Carabello BA, Chatterjee K; et al. (2008). "2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 118 (15): e523–661. doi:10.1161/CIRCULATIONAHA.108.190748. PMID 18820172. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources